Category

• Products2

Organizations

• Bausch + Lomb66
• Eyes On Eyecare47
• Alcon, Inc.44
• American Optometric Association35
• Harrow29
• Glaukos26
• Regeneron23
• Topcon Healthcare23
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA2
• Eye Drops2
• Generics2
• Products2
• Fda Approval1
• IOP1
• Ocular Hypertension1
• Corticosteroids1
• Eye Drop Solution1
• Glaucoma1

• Organizations: Alembic Pharmaceuticals✕

Clear all

Products

FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension

Generic of Bausch + Lomb’s ZYLET for steroid-responsive inflammatory ocular conditions qualifies for 6 months of market exclusivity once commercially launched.

Products

Generic brimonidine ophthalmic solution launches for IOP reduction

Alembic Pharmaceuticals’ generic formulation is indicated to reduce IOP in patients with OAG and OHT.